254 related articles for article (PubMed ID: 16435382)
21. Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome.
Silvana B; Antonella LM; Basilia P; Trombetta D; Saija A; Salpietro C
Pediatr Transplant; 2007 Aug; 11(5):552-6. PubMed ID: 17631027
[TBL] [Abstract][Full Text] [Related]
22. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
[TBL] [Abstract][Full Text] [Related]
23. Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency.
Wakim M; Shah A; Arndt PA; Garratty G; Weinberg K; Hofstra T; Church J
Am J Hematol; 2004 Jun; 76(2):152-5. PubMed ID: 15164382
[TBL] [Abstract][Full Text] [Related]
24. Rituximab in autoimmune hematologic diseases: not just a matter of B cells.
Stasi R
Semin Hematol; 2010 Apr; 47(2):170-9. PubMed ID: 20350664
[TBL] [Abstract][Full Text] [Related]
25. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
26. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
van Daalen ST; van Dijken PJ; Tamminga RY; Brons PP
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2350-4. PubMed ID: 16261716
[TBL] [Abstract][Full Text] [Related]
27. B cell-targeted therapy in diseases other than rheumatoid arthritis.
Looney RJ
J Rheumatol Suppl; 2005 Feb; 73():25-8; discussion 29-30. PubMed ID: 15693113
[TBL] [Abstract][Full Text] [Related]
28. Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodies.
Webster D; Ritchie B; Mant MJ
Am J Hematol; 2004 Apr; 75(4):258-9. PubMed ID: 15054824
[TBL] [Abstract][Full Text] [Related]
29. Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximab.
Papakonstantinou G; Loeffler H; Haferlach T; Brugger W
Eur J Haematol; 2010 Jun; 84(6):547-9. PubMed ID: 20113334
[TBL] [Abstract][Full Text] [Related]
30. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.
Provan D; Butler T; Evangelista ML; Amadori S; Newland AC; Stasi R
Haematologica; 2007 Dec; 92(12):1695-8. PubMed ID: 18055995
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation.
Haller W; Hind J; Height S; Mitry R; Dhawan A
Pediatr Transplant; 2010 May; 14(3):E20-5. PubMed ID: 19254271
[TBL] [Abstract][Full Text] [Related]
32. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
Stübgen JP
J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
[TBL] [Abstract][Full Text] [Related]
33. [Autoimmune hemolytic anemia].
Berentsen S; Sundic T; Hervig T; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2226-31. PubMed ID: 19898570
[TBL] [Abstract][Full Text] [Related]
34. Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease.
Keung YK; Cobos E; Bolanos-Meade J; Issarachai S; Brideau A; Morgan D
Bone Marrow Transplant; 1997 Dec; 20(12):1099-101. PubMed ID: 9466285
[TBL] [Abstract][Full Text] [Related]
35. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
36. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
37. [Immunologic thrombopenic purpura associated with an autoimmune hemolytic anemia or Fisher-Evans syndrome: apropos of a case].
Ndiaye O; Sylla A; Ndiaye FS; Diagne I; Diallo-Chauvin M; Diouf S; Sallm G; Kuakuvi K
Dakar Med; 1999; 44(2):240-2. PubMed ID: 11957294
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up.
Rückert A; Glimm H; Lübbert M; Grüllich C
Lupus; 2008 Aug; 17(8):757-60. PubMed ID: 18625656
[TBL] [Abstract][Full Text] [Related]
39. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
40. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
